STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Oncology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijo.2012.1568PMID 22842992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promise and challenge of RNA interference-based therapy for cancer.

  2011cited by this paper
• SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation

  2011cited by this paper
• MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.

  2011cited by this paper
• Mechanisms of Resistance to EGFR TKIs and Development of a New Generation of Drugs in Non-Small-Cell Lung Cancer

  2011cited by this paper
• Importins Are Critical for Colorectal Cancer (CRC) Growth and Are Novel Biomarkers of CRC. Underlying Mechanisms Include: Increased Nuclear Transport of P-CREB and P-STAT3, VEGF Gene Promoter Activation and Aberrant VEGF Expression

  2011cited by this paper
• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

  2011cited by this paper
• Hypoxia-induced SOCS3 is limiting STAT3 phosphorylation and NF-κB activation in congenital heart disease.

  2011cited by this paper
• Protein inhibitor of activated STAT3 expression in lung cancer

  2011cited by this paper
• Stat3 as a therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, a Stat3 inhibitor.

  2011cited by this paper
• Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.

  2011cited by this paper
• Prognostic significance of STAT3 and phosphorylated STAT3 in human soft tissue tumors - a clinicopathological analysis

  2011cited by this paper
• A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells

  2011cited by this paper
• The Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Induces Apoptosis in Medulloblastoma and Glioblastoma Cells

  2011cited by this paper
• STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers

  2011cited by this paper
• The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB‐exposed mouse skin

  2011cited by this paper
• Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.

  2011cited by this paper
• Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.

  2011cited by this paper
• A phase I, open-label, nonrandomized trial of OPB-31121, a STAT3 inhibitor, in patients with advanced solid tumors.

  2010cited by this paper
• A Novel Direct STAT3 Inhibitor OPB-31121 Induces Tumor-Specific Growth Inhibition In a Wide Range of Hematopoietic Malignancies and Effectively Suppresses the Chemotherapy Resistant Quiescent Cells In Vivo

  2010cited by this paper
• Abstract 2105:miR-125bpromotes the tumor growth of prostate cancer cells in intact and castrated male nude mice

  2010cited by this paper
• A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.

  2010cited by this paper
• STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer.

  2010cited by this paper
• A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes.

  2010cited by this paper
• Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.

  2010cited by this paper
• Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.

  2010cited by this paper
• Etiological Analysis of Neurodevelopmental Disabilities: Single-Center Eight-Year Clinical Experience in South China

  2010cited by this paper
• Identification of a New Series of STAT3 Inhibitors by Virtual Screening.

  2010cited by this paper
• MicroRNA reexpression as differentiation therapy in cancer.

  2009cited by this paper
• Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein.

  2009cited by this paper
• miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation.

  2009cited by this paper
• LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model

  2009cited by this paper
• Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer

  2009cited by this paper
• Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer

  2009cited by this paper
• Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities

  2009cited by this paper
• The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

  2009cited by this paper
• Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo

  2009cited by this paper
• Novel high-throughput screening system for identifying STAT3-SH2 antagonists.

  2009cited by this paper
• Insulin‐like growth factor‐I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK‐STAT) pathway

  2009cited by this paper
• Design, synthesis, and studies of small molecule STAT3 inhibitors.

  2008cited by this paper
• Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway.

  2008cited by this paper
• Mild, efficient and rapid O-debenzylation of ortho-substituted phenols with trifluoroacetic acid

  2008cited by this paper
• Role of Stat3 in suppressing anti-tumor immunity.

  2008cited by this paper
• Constitutively Activated STAT3 Frequently Coexpresses with Epidermal Growth Factor Receptor in High-Grade Gliomas and Targeting STAT3 Sensitizes Them to Iressa and Alkylators

  2008cited by this paper
• Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

  2008cited by this paper
• Deregulation of a STAT3–Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness

  2008cited by this paper
• Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells

  2007cited by this paper
• STAT 3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells *

  2007cited by this paper
• Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

  2007cited by this paper
• Stat3 activation in human endometrial and cervical cancers

  2007cited by this paper
• Tumour immunology: Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment

  2007cited by this paper
• STAT‐mediated EGFR signaling in cancer

  2007cited by this paper
• The MicroRNA let-7a Modulates Interleukin-6-dependent STAT-3 Survival Signaling in Malignant Human Cholangiocytes*

  2007cited by this paper
• An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects.

  2007cited by this paper
• Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

  2007cited by this paper
• Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.

  2007cited by this paper
• STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells*

  2007cited by this paper
• Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor.

  2006cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition

  2006cited by this paper
• Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.

  2006cited by this paper
• STAT3 as a therapeutic target in head and neck cancer

  2006cited by this paper
• Targeting Signal‐Transducer‐and‐Activator‐of‐Transcription‐3 for Prevention and Therapy of Cancer

  2006cited by this paper
• Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions

  2006cited by this paper
• EMBRYONIC STEM CELLS: CHARACTERIZATION SERIES Specific MicroRNAs Modulate Embryonic Stem Cell–Derived

  2006cited by this paper
• let-7 microRNA functions as a potential growth suppressor in human colon cancer cells.

  2006cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• Activation of STAT3 is a marker of poor prognosis in human colorectal cancer.

  2006cited by this paper
• Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells

  2006cited by this paper
• Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.

  2006cited by this paper
• Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo

  2005cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• Composition and Assembly of STAT-Targeting Ubiquitin Ligase Complexes: Paramyxovirus V Protein Carboxyl Terminus Is an Oligomerization Domain

  2005cited by this paper
• Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer Cells

  2005cited by this paper
• Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

  2005cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor Survival In vivo in Non–Small Cell Lung Cancer

  2005cited by this paper
• Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines.

  2005cited by this paper
• A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.

  2005cited by this paper
• Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

  2005cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols

  2004cited by this paper
• Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C.

  2004cited by this paper
• Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

  2004cited by this paper
• TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3

  2004cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.

  2004cited by this paper
• Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis

  2004cited by this paper
• Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.

  2004cited by this paper
• Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

  2004cited by this paper
• Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells

  2003cited by this paper
• Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis

  2003cited by this paper
• Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck.

  2003cited by this paper
• Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway

  2003cited by this paper
• STAT-3 activity in chemically-induced hepatocellular carcinoma.

  2003cited by this paper
• Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system.

  2003cited by this paper
• Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.

  2003cited by this paper
• Stat3 activation in prostatic carcinomas

  2002cited by this paper
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

  2002cited by this paper
• PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells.

  2002cited by this paper
• Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

  2002cited by this paper

• Pulchinenoside E2: A dual-functional STAT3 and autophagy inhibitor with potent anti-metastatic activity in triple-negative breast cancer.

  2025cites this paper
• Unravelling molecular mechanism of oral squamous cell carcinoma and genetic landscape: an insight into disease complexity, available therapies, and future considerations

  2025cites this paper
• Sensitisation of HeLa Cell Cultures to Xanthone Treatment by RNAi-Mediated Silencing of NANOG and STAT3

  2025cites this paper
• OZ-001 Suppresses the Growth of Triple-Negative Breast Cancer and Pancreatic Cancer by Targeting STAT3 Phosphorylation and the Calcium Signaling Pathway

  2025cites this paper
• Schisanhenol Inhibits the Proliferation of Hepatocellular Carcinoma Cells by Targeting Programmed Cell Death-ligand 1 via the STAT3 Pathways.

  2025cites this paper
• Advancements in the understanding of mechanisms of the IL-6 family in relation to metabolic-associated fatty liver disease

  2025cites this paper
• Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential

  2024cites this paper
• Research progress of multi-target HDAC inhibitors blocking the BRD4-LIFR-JAK1-STAT3 signaling pathway in the treatment of cancer.

  2024cites this paper
• Effect of Soy Isoflavone on Prostate Cancer Cell Apoptosis Through Inhibition of STAT3, ERK, and AKT

  2024cites this paper
• Banxia Xiexin Decoction inhibits colitis-associated colorectal cancer development by modulating STAT3 signaling and gut microbiota

  2024cites this paper
• Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy.

  2024cites this paper
• A strategic review of STAT3 signaling inhibition by phytochemicals for cancer prevention and treatment: An update.

  2024cites this paper
• pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy

  2024cites this paper
• STAG2 promotes naive-primed transition via activating Lin28a transcription in mouse embryonic stem cells

  2024cites this paper
• Combined effects of naringin and doxorubicin on the JAK/STAT signaling pathway reduce the development and spread of breast cancer cells

  2024cites this paper
• Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma

  2024cites this paper
• In-silico assessment of novel peptidomimetics inhibitor targeting STAT3 and STAT4 N-terminal domain dimerization: A comprehensive study using molecular docking, molecular dynamics simulation, and binding free energy analysis.

  2024cites this paper
• Targeting STAT3-Mediated Autophagy with Small Molecules in Cancer Treatment - A Comprehensive Review

  2024cites this paper
• Evaluation of premetastatic changes in lymph nodes(pN0) of oral tongue tumour: A prospective observational Study

  2023cites this paper
• Research on the Regulatory Mechanism of Ginseng on the Tumor Microenvironment of Colorectal Cancer based on Network Pharmacology and Bioinformatics Validation.

  2023cites this paper
• ZNF70 regulates IL-1β secretion of macrophages to promote the proliferation of HCT116 cells via activation of NLRP3 inflammasome and STAT3 pathway in colitis-associated colorectal cancer.

  2023cites this paper
• Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter

  2023cites this paper
• A Glance at Biogenesis and Functionality of MicroRNAs and Their Role in the Neuropathogenesis of Parkinson's Disease

  2023cites this paper
• Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update.

  2023cites this paper
• Advances in the role of STAT3 in macrophage polarization

  2023cites this paper
• Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells

  2023cites this paper
• miR-133b Promotes Esophageal Squamous Cell Carcinoma Metastasis

  2023cites this paper
• Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations

  2023cites this paper
• Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes

  2023cites this paper
• Antimetastatic activity of seongsanamide B in γ-irradiated human lung cancer

  2023cites this paper
• Downregulation of miR-125a-5p leads to STAT3 Increased Expression in Breast Cancer Patients.

  2022cites this paper
• Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells

  2022cites this paper
• Long Non-coding RNA H19 Deteriorates Hypoxic-Ischemic Brain Damage by Interacting with MicroRNA-140-5p and STAT3

  2022cites this paper
• Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment.

  2022cites this paper
• Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy

  2022cites this paper
• Minecoside promotes apoptotic progression through STAT3 inactivation in breast cancer cells

  2022influential citation
• The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer

  2022influential citation
• Anticancer activity of IRAK-4 inhibitors against canine lymphoid malignancies.

  2022cites this paper
• Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach.

  2021cites this paper
• Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells

  2021cites this paper
• LRG1 Promotes Metastatic Dissemination of Melanoma through Regulating EGFR/STAT3 Signalling

  2021cites this paper
• Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease.

  2021cites this paper
• lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma.

  2021cites this paper
• Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling

  2021cites this paper
• Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and MDA-MB-468 breast cancer cells

  2021cites this paper
• Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer.

  2021cites this paper
• Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.

  2021cites this paper
• Targeting Tumor–Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer

  2021cites this paper
• Synthesis and Antiproliferative Activity of Ester Derivatives of Mogrol through JAK2/STAT3 Pathway

  2021cites this paper
• Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling

  2021cites this paper
• A Brief Update on STAT3 Signaling: Current Challenges and Future Directions in Cancer Treatment

  2021cites this paper
• Costunolide, a Sesquiterpene Lactone, Suppresses Skin Cancer via Induction of Apoptosis and Blockage of Cell Proliferation

  2021cites this paper
• Redox regulation of DUBs and its therapeutic implications in cancer

  2021influential citation
• Albendazole Exhibits Anti-Neoplastic Actions against Gastric Cancer Cells by Affecting STAT3 and STAT5 Activation by Pleiotropic Mechanism(s)

  2021cites this paper
• Arylidenes of Quinolin-2-one scaffold as Erlotinib analogues with activities against leukemia through inhibition of EGFR TK/ STAT-3 pathways.

  2020cites this paper
• miR-634 Decreases the Radioresistance of Human Breast Cancer Cells by Targeting STAT3

  2020cites this paper
• GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation

  2020cites this paper
• The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas

  2020cites this paper
• STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells

  2020cites this paper
• Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.

  2020cites this paper
• Natural Salicylates and Their Roles in Human Health

  2020cites this paper
• cacy of combination treatment using YHO-1701 , an orally active STAT 3 inhibitor , with molecular-targeted agents on cancer cell lines

  2020cites this paper
• Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines

  2020cites this paper
• STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection

  2020cites this paper
• An Electrophilic Deguelin Analogue Inhibits STAT3 Signaling in H-Ras-Transformed Human Mammary Epithelial Cells: The Cysteine 259 Residue as a Potential Target

  2020cites this paper
• A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception

  2020cites this paper
• Down‐regulation of microRNA‐34c‐5p alleviates neuropathic pain via the SIRT1/STAT3 signaling pathway in rat models of chronic constriction injury of sciatic nerve

  2020cites this paper
• Trichothecin Inhibits Cancer-Related Features in Colorectal Cancer Development by Targeting STAT3

  2020cites this paper
• BP-1-102 and silencing of Fascin-1 by RNA interference inhibits the proliferation of mouse pituitary adenoma AtT20 cells via the signal transducer and activator of transcription 3/fascin-1 pathway

  2020cites this paper
• Physalis alkekengi var. franchetii extracts exert anti-tumour effects on non-small cell lung cancer and multiple myeloma by inhibiting STAT3 signalli

  2020cites this paper
• A novel small molecule STAT3 inhibitor SLSI-1216 suppresses proliferation and tumor growth of triple-negative breast cancer cells through apoptotic induction.

  2020cites this paper
• TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis.

  2019cites this paper
• SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone.

  2019cites this paper
• STAT3beta, a distinct isoform from STAT3.

  2019cites this paper
• STAT3 Inhibitors as Sensitizing Agents for Cancer Chemotherapy

  2019cites this paper
• MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells

  2019cites this paper
• Ferulic acid maintains the self-renewal capacity of embryo stem cells and adipose-derived mesenchymal stem cells in high fat diet-induced obese mice.

  2019cites this paper
• A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.

  2019cites this paper
• Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo.

  2019cites this paper
• Bradykinin promotes proliferation, migration, and invasion of cervical cancer cells through STAT3 signaling pathways

  2019cites this paper
• STAT3 isoforms: Alternative fates in cancer?

  2019cites this paper
• Inhibition of JAK2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells.

  2019cites this paper
• Atiprimod induce apoptosis in pituitary adenoma: Endoplasmic reticulum stress and autophagy pathways

  2019cites this paper
• Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin

  2019cites this paper
• miR-124 and Parkinson's disease: a biomarker with therapeutic potential.

  2019cites this paper
• Discovery of fluorescent coumarin-benzo[b]thiophene 1, 1-dioxide conjugates as mitochondria-targeting antitumor STAT3 inhibitors.

  2019cites this paper
• Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.

  2019cites this paper
• Development of an HPLC-UV Method for Quantification of Stattic

  2019cites this paper
• Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad

  2019cites this paper
• STAT3 cyclic oligonucleotide decoy-a new therapeutic avenue for NSCLC?

  2018cites this paper
• Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway

  2018cites this paper
• The multifaceted STAT3: How a transcription factor regulates Ca2+ signaling via a degradative pathway.

  2018cites this paper
• Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.

  2018cites this paper
• Two decades of research in discovery of anticancer drugs targeting STAT3, how close are we?

  2018cites this paper
• Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer

  2018cites this paper
• Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors.

  2018cites this paper
• Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors

  2018cites this paper
• Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M

  2018cites this paper
• bFGF-mediated pluripotency maintenance in human induced pluripotent stem cells is associated with NRAS-MAPK signaling

  2018cites this paper
• Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens

  2018cites this paper